Spots Global Cancer Trial Database for carcinoma, pancreatic ductal
Every month we try and update this database with for carcinoma, pancreatic ductal cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma | NCT02928081 | Carcinoma, Panc... | Extended lympha... Standard lympha... | 18 Years - 75 Years | West China Hospital | |
| Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | NCT00471146 | Carcinoma, Panc... | AG-013736 Gemcitabine Gemcitabine placebo | 18 Years - | Pfizer | |
| Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | NCT00471146 | Carcinoma, Panc... | AG-013736 Gemcitabine Gemcitabine placebo | 18 Years - | Pfizer | |
| Continuous Monitoring on the General Ward | NCT02933307 | Carcinoma, Panc... Colorectal Neop... Arthritis Hypertension Sepsis | HealthPatch ViSi Mobile | 18 Years - 85 Years | Radboud University Medical Center | |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | NCT02993731 | Carcinoma, Panc... | Napabucasin Nab-paclitaxel Gemcitabine | 18 Years - | Sumitomo Pharma America, Inc. | |
| CT Pancreas Perfusion | NCT00588367 | Pancreatic Duct... Chronic Pancrea... Autoimmune Panc... | Mayo Interactiv... | 18 Years - | Mayo Clinic | |
| Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. | NCT03500068 | Carcinoma, Panc... | biopsies & bloo... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | NCT00471146 | Carcinoma, Panc... | AG-013736 Gemcitabine Gemcitabine placebo | 18 Years - | Pfizer | |
| An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy | NCT02310230 | Biliary Tract D... Stomach Neoplas... Carcinoma, Panc... Barrett Esophag... | ExSpiron Respir... | 21 Years - | University of Vermont | |
| Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection | NCT02750657 | Carcinoma, Panc... | Molecular Profi... | 18 Years - | University Health Network, Toronto | |
| Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients | NCT02456051 | Diabetes Mellit... Diabetes Compli... Carcinoma, Panc... Pancreatic Neop... | 45 Years - 75 Years | University of Roma La Sapienza | ||
| Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | NCT00471146 | Carcinoma, Panc... | AG-013736 Gemcitabine Gemcitabine placebo | 18 Years - | Pfizer | |
| Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection | NCT02750657 | Carcinoma, Panc... | Molecular Profi... | 18 Years - | University Health Network, Toronto | |
| Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer | NCT01394120 | Carcinoma, Panc... | Targeted Therap... Standard Chemot... | 18 Years - | Grupo Hospital de Madrid | |
| Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer | NCT03432624 | Carcinoma, Panc... | Serum MicroRNA-... | 18 Years - | Fudan University | |
| Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma | NCT02928081 | Carcinoma, Panc... | Extended lympha... Standard lympha... | 18 Years - 75 Years | West China Hospital | |
| Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study. | NCT05723978 | Carcinoma, Panc... | Selective exten... | - | Tianjin Medical University Cancer Institute and Hospital | |
| A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS | NCT05379985 | Non-small Cell ... Colorectal Canc... Pancreatic Duct... Advanced Solid ... | RMC-6236 | 18 Years - | Revolution Medicines, Inc. | |
| The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer | NCT03403101 | Carcinoma, Panc... | S1 Oxaliplatin Irinotecan | 18 Years - 75 Years | Fudan University | |
| EUS Shear Wave for Solid Pancreatic Lesions. | NCT05095831 | Pancreas Neopla... Pancreatitis Pancreatitis, A... Pancreatitis, C... Pancreatitis, A... | Pancreas EUS sh... Pancreas EUS-el... | 18 Years - 79 Years | Instituto Ecuatoriano de Enfermedades Digestivas | |
| Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer | NCT02653313 | Carcinoma, Panc... | Parvovirus H-1 ... | 18 Years - | Oryx GmbH & Co. KG | |
| The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer | NCT03403101 | Carcinoma, Panc... | S1 Oxaliplatin Irinotecan | 18 Years - 75 Years | Fudan University | |
| Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1) | NCT03513705 | Carcinoma, Panc... | Best practices ... | - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) | NCT01808638 | Carcinoma, Panc... | Atu027 & gemcit... Atu027 & gemcit... Atu027 & gemcit... | 18 Years - 84 Years | Silence Therapeutics GmbH | |
| Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer | NCT02653313 | Carcinoma, Panc... | Parvovirus H-1 ... | 18 Years - | Oryx GmbH & Co. KG | |
| Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas | NCT02817308 | Carcinoma, Panc... | samples of bloo... | 18 Years - | Rambam Health Care Campus | |
| Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) | NCT01808638 | Carcinoma, Panc... | Atu027 & gemcit... Atu027 & gemcit... Atu027 & gemcit... | 18 Years - 84 Years | Silence Therapeutics GmbH | |
| CT Pancreas Perfusion | NCT00588367 | Pancreatic Duct... Chronic Pancrea... Autoimmune Panc... | Mayo Interactiv... | 18 Years - | Mayo Clinic | |
| A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 | NCT01608711 | Pancreatic Canc... Carcinoma, Panc... Pancreatic Dise... | AGS-1C4D4 gemcitabine | 18 Years - | Astellas Pharma Inc | |
| Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures | NCT05475366 | Carcinoma, Panc... Prognosis | Clinical value ... Biomarkers of t... | 18 Years - 75 Years | Institut Curie | |
| Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma | NCT02928081 | Carcinoma, Panc... | Extended lympha... Standard lympha... | 18 Years - 75 Years | West China Hospital | |
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899636 | Stage III Pancr... | Modified FOLFIR... NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) | NCT01808638 | Carcinoma, Panc... | Atu027 & gemcit... Atu027 & gemcit... Atu027 & gemcit... | 18 Years - 84 Years | Silence Therapeutics GmbH | |
| A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 | NCT01608711 | Pancreatic Canc... Carcinoma, Panc... Pancreatic Dise... | AGS-1C4D4 gemcitabine | 18 Years - | Astellas Pharma Inc | |
| A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | NCT02231723 | Metastatic Panc... | BBI608 Nab-paclitaxel Gemcitabine Oxaliplatin Leucovorin Irinotecan Fluorouracil MM-398 | 18 Years - | Sumitomo Pharma America, Inc. | |
| Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. | NCT03500068 | Carcinoma, Panc... | biopsies & bloo... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer | NCT00902291 | Carcinoma, Panc... Pancreatic Canc... Pancreatic Dise... | AGS-1C4D4 Gemcitabine | 18 Years - | Astellas Pharma Inc | |
| Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. | NCT03500068 | Carcinoma, Panc... | biopsies & bloo... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors | NCT01478685 | Urinary Bladder... Carcinoma, Tran... Ovarian Neoplas... Fallopian Tube ... Peritoneal Neop... Carcinoma, Non-... Carcinoma, Panc... Tumor Virus Inf... | CC-486 Carboplatin ABI-007 | 18 Years - | Celgene | |
| The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer | NCT03403101 | Carcinoma, Panc... | S1 Oxaliplatin Irinotecan | 18 Years - 75 Years | Fudan University | |
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899636 | Stage III Pancr... | Modified FOLFIR... NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors | NCT01478685 | Urinary Bladder... Carcinoma, Tran... Ovarian Neoplas... Fallopian Tube ... Peritoneal Neop... Carcinoma, Non-... Carcinoma, Panc... Tumor Virus Inf... | CC-486 Carboplatin ABI-007 | 18 Years - | Celgene | |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) | NCT05461430 | Pleural Effusio... Ascites, Malign... Carcinoma Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Rena... Carcinoma, Smal... Carcinoma, Non-... Carcinoma, Panc... Carcinoma, Neur... Carcinoma, Thym... Carcinoma, Panc... Carcinoma Breas... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Es... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Cholangiocarcin... Melanoma Mesothelioma Pancreatic Canc... | 18 Years - | Travera Inc | ||
| Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma | NCT04146441 | Carcinoma, Panc... | SonoVue Chemotherapy | 19 Years - 89 Years | St. Olavs Hospital | |
| Amatuximab for High Mesothelin Cancers | NCT01413451 | Carcinoma, Panc... Mesothelioma Ovarian Neoplas... Carcinoma, Non-... | Amatuximab (MOR... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
